“…The studies included in this review presented qualitative design (Eslami et al, 2016;Ledesma et al, 2013;Lee et al, 2016), quantitative design (Chhetri et al, 2020;Grapsa et al, 2014;Pereira et al, 2017;Tuckey et al, 2022;Chan et al, 2016), and mixed design (Vieira et al, 2021). Regarding evidence level, 89% of the studies were classified as level III (nonexperimental studies, qualitative studies, or meta-synthesis studies) (Chhetri et al, 2020; Brazilian Journal of Health Review, Curitiba, v. 6, n. 2, p.5620-5638, mar./apr., 2023 Grapsa et al, 2014;Pereira et al, 2017;Tuckey et al, 2022;Eslami et al, 2016;Ledesma et al, 2013;Lee et al, 2016;Vieira et al, 2021), and 11% were classified as level I -the highest evidence level (randomized clinical trials, systematic reviews, and meta-analyses) (Chan et al, 2016). Regarding the evidence quality evaluation, all articles were classified as B (good quality) (Table 2).…”